We are happy to feature two important pieces of research that with your
amazing donations The Butterfly AVM Charity have funded in partnership with
the Royal Free Hospital and UCL that could potentially develop an
engineering framework to personalize the management of AVMs and find a
biomarker for AVMs both of value in diagnosis and monitoring of successful
treatment whilst targeting specific gene expression changes that cause
increased endothelial cell activity.

Please click the below links to view the updates:

Engineering report 2022
Final report for The Butterfly AVM Charity

Follow us on